Abstract
Erythropoietic protoporphyria (EPP) is a rare disease with painful cutaneous photosensitivity, in which patients are recommended to avoid sun exposure, and wear sunscreen and adequate clothing. Our aim was to study bone mineral density (BMD) and other mineral parameters, including serum 25(OH)D levels, to evaluate the impact of these measures in the follow-up of EPP patients. A cross-sectional study of ten EPP patients (median age 25; range 22–55, four males and six females), was performed evaluating clinical features, biochemical values (bone markers and serum 25 hydroxyvitamin D), and BMD. Median serum 25(OH)D level was 19.65 ng/ml [17.50; 24.80]. Four patients had 25(OH)D in insufficiency range (20–30 ng/ml) and five patients in the deficiency range (<20 ng/ml). Lumbar T-score median levels were in the osteopenia range in both females (−1.50 [−2.30; −1.0]) and males (−1.90 [−2.40; −0.70]). Also, in the female group median femoral neck T-score were in the osteopenia range (−1.20 [−1.60; −0.60]). This is the first study reporting low BMD in EPP patients. Osteoporosis, osteopenia, and vitamin D deficiency are frequent findings in EPP patients. The contribution of sunlight avoidance measures to these results remains to be clarified. Serum levels of protoporphyrins were not related to these alterations and other factors should be investigated. We suggest that the monitoring of serum vitamin D levels in EPP patients should be mandatory, as well as vitamin D and calcium supplementation.
Similar content being viewed by others
References
A. Faurschou, D.M. Beyer, A. Schmedes, M.K. Bogh, P.A. Philipsen, H.C. Wulf, The relation between sunscreen layer thickness and vitamin D production after ultraviolet B exposure: a randomized clinical trial. Br. J. Dermatol. 167, 391–395 (2012)
J.W. Diehl, M.W. Chiu, Effects of ambient sunlight and photoprotection on vitamin D status. Dermatol. Ther. 23, 48–60 (2010)
H.M. Mcdonald, Contributions of sunlight and diet to vitamin D status. Calcif. Tissue Int. 92(2), 163–176 (2013)
G. Mazziotti, J. Bilezikian, E. Canalis, D. Cocchi, A. Giustina, New understanding and treatment for osteoporosis. Endocrine 41, 58–69 (2012)
M.F. Holick, Vitamin D deficiency. N. Engl. J. Med. 357(3), 266–281 (2007)
World Health Organization Scientific Group Research on Menopause. WHO Technical Service Report Series 670, WHO Geneva (1998)
M. Diaz Curiel, J.L. Carrasco de la Pena, J. Honorato Perez, R. Perez Cano, A. Rapado, I. Ruiz Martinez, Study of bone mineral density in lumbar spine and femoral neck in a Spanish population. Multicentre research project on osteoporosis. Osteoporos. Int. 7, 59–64 (1997)
S. Piomelli, Free erythrocyte porphyrins in the detection of undue absorption of Pb and of Fe deficiency. Clin. Chem. 23(2 Pt 1), 264–269 (1977)
J.M. Spelt, F.W. de Rooij, J.H. Wilson, A.A. Zandbergen, Vitamin D deficiency in patients with erythropoietic protoporphyria. J. Inherit. Metab. Dis. (2009). doi:10.1007/s10545-008-1037-0
S.A. Holme, A.V. Anstey, M.N. Badminton, G.H. Elder, Serum 25-hydroxyvitamin D in erythropoietic protoporphyria. Br. J. Dermatol. 159(1), 211–213 (2008)
S. Wahlin, Y. Floderus, P. Stal, P. Harper, Erythropoietic protoporphyria in Sweden: demographic, clinical, biochemical and genetic characteristics. J. Intern. Med. 269, 278–288 (2010)
M. Calatayud, E. Jódar, R. Sánchez, S. Guadalix, F. Hawkins, Prevalence of deficient and insufficient vitamin D levels in a young healthy population. Endocrinol. Nutr. 56(4), 164–169 (2009)
L.Y. Matsuoka, L. Ide, J. Wortsman, J.A. MacLaughlin, M.F. Holick, Sunscreens suppress cutaneous vitamin D3 synthesis. J. Clin. Endocrinol. Metab. 64, 1165–1168 (1987)
R. Marks, P.A. Foley, D. Jolley, K.R. Knight, J. Harrison, S.C. Thompson, The effect of regular sunscreen use on vitamin D levels in an Australian population. Arch. Dermatol. 131, 415–421 (1995)
M. Kimlin, S. Harrison, M. Novak, M. Moore, A. Brodie, C. Lang, Does a high UV environment ensure adequate vitamin D status? J. Photochem. Photobiol. B 89, 139–147 (2007)
J. Farrerons, M. Barnadas, A. Lopez Navidad, A. Renau, J. Rodriguez, B. Yoldi, A. Alomar, Sunscreen and risk of osteoporosis in the elderly: a two year follow-up. Dermatology 202, 27–30 (2001)
T. Montalcini, S. Romeo, Y. Ferro, V. Migliaccio, C. Gazzaruso, A. Pujia, Osteoporosis in chronic inflammatory disease: the role of malnutrition. Endocrine 43, 59–64 (2013)
J.D. Adachi, K. Saag, P.D. Delmas, U.A. Liberman, Rd. Emkey, E. Seeman, N.E. Lane, J.M. Kaufman, P.E.E. Pubelle, F. Hawkins, R. Correa, C.J. Mankes, J.A. Rodriguez, T.J. Schnitzer, Ja. Block, J. wing, H.H. McIlwain, R. Westhovens, J. Brown, J.A. Melo, B.L. Gruber, M. Yanovr, M.O.R. Leite, K.G. Siminoski, M.C. Nevitt, J.T. Sharp, M.P. Malice, T. Dumortier, M. Czachur, W. Carofano, A. Dafoitis, Two year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoides. Arthritis Rheum. 44, 202–211 (2001)
A. Angeli, G. Guglielmi, A. Dovio, G. Capelli, Ç.D. de Feo, S. Giannini, R. Giorgino, L. Moro, A. Giustina, High prevalence of asymtptomatic vertebral fractures in postmenopasual women receiving chronic glugocorticoid therapy: a cross sectional outpatient study. Bone 39, 253–259 (2006)
G. Mazziotti, A. Bianchi, S. Bonadonna, V. Cimino, I. Patelli, A. Fusco, A. Pontecorvi, L. De Marinis, A. Giustina, Prevalence of vertebral fractures in men with acromegaly. J. Clin. Endocirnol. Metab. 93, 4649–4655 (2008)
P. Qvist, S. Christgau, B.J. Pedersen, A. Schlemmer, C. Christiansen, Circadian variation in the serum concentration of C-terminal telopeptide of type I collagen (serum CTx): effects of gender, age, menopausal status, posture, daylight, serum cortisol, and fasting. Bone 31(1), 57–61 (2002)
Acknowledgments
We thank Mary Solari for her help in the English review of this manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Allo, G., del Carmen Garrido-Astray, M., De Salamanca, R.E. et al. Bone mineral density and vitamin D levels in erythropoietic protoporphyria. Endocrine 44, 803–807 (2013). https://doi.org/10.1007/s12020-013-9934-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-013-9934-x